Letter to the EditorGenome-edited MSCs that express GCP-2 and SDF-1α might be a novel therapeutic strategy for the treatment of ischemic vascular disease
Section snippets
Conflict of interest
The authors report no relationships that could be construed as a conflict of interest.
Transparency document
References (5)
- et al.
Dual chemotactic factors-secreting human amniotic mesenchymal stem cells via TALEN-mediated gene editing enhanced angiogenesis
Int. J. Cardiol.
(2018) - et al.
Amniotic mesenchymal stem cells with robust chemotactic properties are effective in the treatment of a myocardial infarction model
Int. J. Cardiol.
(2013)
There are more references available in the full text version of this article.
Cited by (1)
Adipose-Derived Stem Cells Transfected with GCP-2 Alleviate Pulmonary Arterial Hypertension in Rats by Modulating Apelin/APJ System and eNOS Signaling
2023, Journal of Biological Regulators and Homeostatic Agents
© 2018 Elsevier B.V. All rights reserved.